108 related articles for article (PubMed ID: 2849806)
1. [Severe complications during enalapril therapy for heart insufficiency].
Wieland T; Stäubli M
Schweiz Med Wochenschr; 1988 Dec; 118(48):1789-92. PubMed ID: 2849806
[TBL] [Abstract][Full Text] [Related]
2. [Severe electrolyte disorders during the therapy of heart failure with the therapy of heart failure with the ACE-inhibitor enalapril].
Hess B; Keusch G; Neftel K; Margelist F; Bansky G
Schweiz Med Wochenschr; 1986 Sep; 116(39):1331-6. PubMed ID: 3022372
[TBL] [Abstract][Full Text] [Related]
3. [Acute reversible kidney insufficiency due to enalapril during diuretic-treated heart insufficiency].
Degenhardt S
Dtsch Med Wochenschr; 1987 Jun; 112(24):960-3. PubMed ID: 3036457
[TBL] [Abstract][Full Text] [Related]
4. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
[TBL] [Abstract][Full Text] [Related]
5. Renal and electrolyte complications of congestive heart failure and effects of therapy with angiotensin-converting enzyme inhibitors.
Oster JR; Materson BJ
Arch Intern Med; 1992 Apr; 152(4):704-10. PubMed ID: 1558426
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
7. Renal effects of angiotensin converting enzyme inhibitors in heart failure: a clinician's guide to minimizing azotemia and diuretic-induced electrolyte imbalances.
Weinberg MS
Clin Ther; 1993; 15(1):3-17; discussion 2. PubMed ID: 8458051
[TBL] [Abstract][Full Text] [Related]
8. [An elderly man with known heart failure admitted with cardiogenic shock].
Hovland A; Fagerheim AK; Hardersen R; Nielsen EW
Tidsskr Nor Laegeforen; 2010 Jul; 130(13):1352-4. PubMed ID: 20596117
[TBL] [Abstract][Full Text] [Related]
9. [Dangerous hyperkalemia as sequelae of new treatment strategies of heart failure].
Fuster D; Frey FJ; Ferrari P
Praxis (Bern 1994); 2000 Dec; 89(49):2073-6. PubMed ID: 11190849
[TBL] [Abstract][Full Text] [Related]
10. Design and analysis of the HYPREN-trial: safety of enalapril and prazosin in the initial treatment phase of patients with congestive heart failure.
Hasford J; Bussmann WD; Delius W; Köpcke W; Lehmann K; Weber E
Z Kardiol; 1991; 80 Suppl 2():21-7. PubMed ID: 2024540
[TBL] [Abstract][Full Text] [Related]
11. [Electrolyte abnormalities and metabolic acidosis in two Duchenne muscular dystrophy patients with advanced congestive heart failure].
Matsumura T; Saito T; Miyai I; Nozaki S; Kang J
Rinsho Shinkeigaku; 2000 May; 40(5):439-45. PubMed ID: 11002725
[TBL] [Abstract][Full Text] [Related]
12. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.
Tamirisa KP; Aaronson KD; Koelling TM
Am Heart J; 2004 Dec; 148(6):971-8. PubMed ID: 15632880
[TBL] [Abstract][Full Text] [Related]
13. Adverse effects of converting-enzyme inhibition in patients with severe congestive heart failure: pathophysiology and management.
Packer M; Kessler PD; Gottlieb SS
Postgrad Med J; 1986; 62 Suppl 1():179-82. PubMed ID: 3022272
[TBL] [Abstract][Full Text] [Related]
14. Renal insufficiency during angiotensin-converting enzyme inhibitor therapy in hypertensive patients with no renal artery stenosis.
Thind GS
J Clin Hypertens; 1985 Dec; 1(4):337-43. PubMed ID: 3014079
[TBL] [Abstract][Full Text] [Related]
15. Enalapril induced persistent hypotension and acute renal failure.
Chhabra SC; Khullar D; Wander GS
J Assoc Physicians India; 1991 Apr; 39(4):350-1. PubMed ID: 1938827
[No Abstract] [Full Text] [Related]
16. [Effect of combined captopril-spironolactone therapy of cardiac insufficiency on kidney function and serum electrolyte values].
Cserhalmi L
Orv Hetil; 1998 Jan; 139(2):63-6. PubMed ID: 9451904
[TBL] [Abstract][Full Text] [Related]
17. Combined use of an ACE-inhibitor and spironolactone in patients with heart insufficiency.
Schröder J; Goltz L; Knoth H
Med Monatsschr Pharm; 2017 Jan; 40(1):24-6. PubMed ID: 29952529
[TBL] [Abstract][Full Text] [Related]
18. [Kidney insufficiency following use of enalapril for congestive heart failure].
Botman CJ; Mulder AW; Hoorntje SJ
Ned Tijdschr Geneeskd; 1987 Aug; 131(32):1402-4. PubMed ID: 2821411
[No Abstract] [Full Text] [Related]
19. Life threatening hyperkalaemia with diarrhoea during ACE inhibition.
McGuigan J; Robertson S; Isles C
Emerg Med J; 2005 Feb; 22(2):154-5. PubMed ID: 15662077
[TBL] [Abstract][Full Text] [Related]
20. Eplerenone: new drug. Recent myocardial infarction with heart failure: a spironolactone me too.
Prescrire Int; 2006 Apr; 15(82):46-9. PubMed ID: 16604728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
